Full text
PDFPage 994

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Jaiyesimi I. A., Buzdar A. U., Decker D. A., Hortobagyi G. N. Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol. 1995 Feb;13(2):513–529. doi: 10.1200/JCO.1995.13.2.513. [DOI] [PubMed] [Google Scholar]
- Knabbe C., Lippman M. E., Wakefield L. M., Flanders K. C., Kasid A., Derynck R., Dickson R. B. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 1987 Feb 13;48(3):417–428. doi: 10.1016/0092-8674(87)90193-0. [DOI] [PubMed] [Google Scholar]
- Lien E. A., Solheim E., Ueland P. M. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res. 1991 Sep 15;51(18):4837–4844. [PubMed] [Google Scholar]
- Perry R. R., Kang Y., Greaves B. R. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer. 1995 Dec;72(6):1441–1446. doi: 10.1038/bjc.1995.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perry R. R., Kang Y., Greaves B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann Surg Oncol. 1995 May;2(3):238–245. doi: 10.1007/BF02307030. [DOI] [PubMed] [Google Scholar]
- Sutherland R. L., Watts C. K., Ruenitz P. C. Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor. Biochem Biophys Res Commun. 1986 Oct 30;140(2):523–529. doi: 10.1016/0006-291x(86)90763-1. [DOI] [PubMed] [Google Scholar]
- Taylor C. M., Blanchard B., Zava D. T. Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. Cancer Res. 1984 Apr;44(4):1409–1414. [PubMed] [Google Scholar]
